ETF Managers Group’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $286K | Buy |
7,080
+1,895
| +37% | +$76.6K | 0.01% | 548 |
|
|
2022
Q4 | $241K | Sell |
5,185
-931
| -15% | -$43.3K | 0.01% | 461 |
|
|
2022
Q3 | $317K | Sell |
6,116
-428
| -7% | -$22.2K | 0.01% | 546 |
|
|
2022
Q2 | $307K | Buy |
6,544
+317
| +5% | +$14.9K | 0.01% | 598 |
|
|
2022
Q1 | $431K | Buy |
6,227
+84
| +1% | +$5.81K | 0.01% | 494 |
|
|
2021
Q4 | $458K | Sell |
6,143
-1,238
| -17% | -$92.3K | 0.01% | 529 |
|
|
2021
Q3 | $414K | Buy |
7,381
+1,424
| +24% | +$79.9K | 0.01% | 566 |
|
|
2021
Q2 | $261K | Sell |
5,957
-222
| -4% | -$9.73K | ﹤0.01% | 595 |
|
|
2021
Q1 | $297K | Sell |
6,179
-3,587
| -37% | -$172K | 0.01% | 589 |
|
|
2020
Q4 | $406K | Sell |
9,766
-1,478
| -13% | -$61.4K | 0.01% | 439 |
|
|
2020
Q3 | $504K | Buy |
11,244
+5,424
| +93% | +$243K | 0.02% | 305 |
|
|
2020
Q2 | $285K | Buy |
+5,820
| New | +$285K | 0.01% | 440 |
|